Recent CABA News
- Securities Registration Statement (simplified Form) (s-3) • Edgar (US Regulatory) • 03/16/2023 12:39:27 PM
- Securities Registration: Employee Benefit Plan (s-8) • Edgar (US Regulatory) • 03/16/2023 11:38:22 AM
- Annual Report (10-k) • Edgar (US Regulatory) • 03/16/2023 11:26:16 AM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 03/16/2023 11:11:54 AM
- Cabaletta Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update • GlobeNewswire Inc. • 03/16/2023 11:00:00 AM
- Cabaletta Bio to Present at the Cowen 43rd Annual Health Care Conference • GlobeNewswire Inc. • 02/28/2023 01:00:00 PM
- Amended Statement of Ownership (sc 13g/a) • Edgar (US Regulatory) • 02/14/2023 09:24:54 PM
- Statement of Ownership (sc 13g) • Edgar (US Regulatory) • 02/14/2023 09:02:32 PM
- Amended Statement of Ownership (sc 13g/a) • Edgar (US Regulatory) • 02/14/2023 08:10:05 PM
- Amended Statement of Ownership (sc 13g/a) • Edgar (US Regulatory) • 02/14/2023 01:16:32 PM
- Amended Statement of Ownership (sc 13g/a) • Edgar (US Regulatory) • 02/14/2023 12:22:02 PM
- Statement of Ownership (sc 13g) • Edgar (US Regulatory) • 02/10/2023 09:05:08 PM
- Amended Statement of Ownership (sc 13g/a) • Edgar (US Regulatory) • 02/09/2023 05:40:23 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 01/09/2023 12:02:53 PM
- Autolus Therapeutics Announces Collaboration with Cabaletta Bio for Use of Autolus’ Safety Switch System in Cell Therapies for Autoimmune Disease • GlobeNewswire Inc. • 01/09/2023 12:00:00 PM
- Cabaletta Bio to Present at the 41st Annual J.P. Morgan Healthcare Conference • GlobeNewswire Inc. • 01/05/2023 01:00:00 PM
- Statement of Ownership (sc 13g) • Edgar (US Regulatory) • 12/23/2022 09:16:29 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 12/12/2022 09:53:48 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 12/08/2022 09:32:31 PM
- Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) • Edgar (US Regulatory) • 12/08/2022 12:11:26 PM
- Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp) • Edgar (US Regulatory) • 12/08/2022 12:07:44 PM
- Cabaletta Bio Announces $35 Million Offering • GlobeNewswire Inc. • 12/08/2022 12:00:00 PM
- Cabaletta Bio to Present at the 5th Annual Evercore ISI HealthCONx Conference • GlobeNewswire Inc. • 11/22/2022 01:00:00 PM
- Chardan Capital Sticks to Their Buy Rating for Cabaletta Bio (CABA) • TipRanks • 11/13/2022 02:25:13 PM
- H.C. Wainwright Sticks to Their Buy Rating for Cabaletta Bio (CABA) • TipRanks • 11/11/2022 11:26:07 AM
FEATURED Fineqia's EEA Unit Receives Approval of Base Prospectus for Issuing Exchange Traded Notes (ETNs) • Mar 28, 2023 9:37 AM
FEATURED Usha Resources Enters Hard-Rock Lithium Space with Acquisition of Significant Ontario Land Package with Highly Evolved LCT-Pegmatites • Mar 28, 2023 8:26 AM
FEATURED Edison Lithium Provides Update on Spin-Out of Cobalt Assets • Mar 28, 2023 8:09 AM
Epazz Holdings: ZenaDrone, Inc. 1000 AI Predictive Received a Letter of Support from the US Airforce for Drone Cargo Delivery and Intent to Use ZenaDrone 1000 Platform • EPAZ • Mar 28, 2023 7:11 AM
Metatron Releases All-in-One Artificial Intelligence Mobile Apps for iPhone and Android • MRNJ • Mar 27, 2023 9:00 AM
Memorandum of Understanding With Miranda Water Treatment Systems and Rainmaker Worldwide Inc. Extended • RAKR • Mar 27, 2023 8:50 AM